Національна наукова медична бібліотека України
Авторизація
Прізвище
Пароль
 

Бази даних


Періодичних видань- результати пошуку

Вид пошуку

Зона пошуку
Формат представлення знайдених документів:
повнийінформаційнийкороткий
Відсортувати знайдені документи за:
авторомназвоюроком виданнятипом документа
Пошуковий запит: <.>A=Conte, G.@<.>
Загальна кількість знайдених документів : 2
Показані документи с 1 за 2
1.
    (Немає відомостей про примірники)
Шифр: N3/2014/29/4
   Журнал

NEPHROLOGY, DIALYSIS, TRANSPLANTATION / European Dialysis and Transplant Association. - Oxford : Oxford University Press. - ISSN 0931-0509. - Виходить щомісячно
2014р. Vol. 29 N 4
Зміст:
Macdougall, I.C. Intravenous iron therapy in non-dialysis CKD patients / I.C. Macdougall. - P.717-720
Denig, P. New renal guidelines; is more better? / P. Denig, Zeeuw de. - P.720-721
Fervenza, F.C. Frequent-relapsing, steroid-dependent minimal change disease: is rituximab the answer? / F.C. Fervenza, S. Sethi. - P.722-727
Quinn, R.R. Fistula-first and catheter-last: fading certainties and growing doubts / R.R. Quinn, P. Ravani. - P.727-730
European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. - P.731-738
Land, J. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody / J. Land, A. Rutgers, C.G.M. Kallenberg. - P.739-745
Lin, M. Toll-like receptors: sensing and reacting to diabetic injury in the kidney / M. Lin, S.C.W. Tang. - P.746-754
Schena, F.P. MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring / F.P. Schena, G. Serino, F. Sallustio. - P.755-763
Kasiske, B.L. Kidney Disease: improving global outcomes - an update / B.L. Kasiske, D.C. Wheeler. - P.763-769
Conte, G. Pro: Thresholds to define chronic kidney disease should not be age-dependent / G. Conte, R. Minutolo, Nicola De. - P.770-774
Glassock, R.J. Con: Thresholds to define chronic kidney desease should not age dependent / R.J. Glassock. - P.774-779
Hallan, S.I. Moderator's View: Should we diagnose CKD using the "one-size fits all" KDIGO 2012 guideline or do we need a more complex age-specific classification system? / S.I. Hallan, R.T. Gansevoort. - P.780-782
Keap 1 inhibition attenuates glomerulosclerosis. - P.783-791
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease. - P.791-799
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are madiated by complement anaphylatoxins and Akt pathway. - P.799-808
Distinct immunologic effects of different intravenous iron preparations on monocytes. - P.809-822
High-perfomance information search filters for acute kidney injury content in PubMed, Ovid Medline and Embase. - P.823-832
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. - P.833-842
The FIND-CKD study - a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. - P.843-850
Rituximab for minimal change in adults: long-term follow-up. - P.851-856
Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. - P.857-864
DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC Study. - P.864-872
Young stroke patients are at high risk for subsequent end-stage renal disease: a population-based observational study. - P.873-878
Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study. - P.878-884
The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. - P.885-892
Health status as a potential mediator of the association between hemodialysis vascular access and mortality. - P.892-898
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. - P.899-905
Haemodialysis in patients treated with oral anticoagulant: should we heparinize?. - P.906-913
Loss of antimicrobial effect of trisodium citrate due to "lock" spillage from haemodialysis catheters. - P.914-919
Spot urine protein measurements in kidney transplantation: a systematic review of diagnostic accurasy. - P.919-926
Short-term efficasy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. - P.926-933
Немає відомостей про примірники
Знайти схожі
Перейти до описів статей

2.


    Conte, G..
    Pro: Thresholds to define chronic kidney disease should not be age-dependent [Text] / G. Conte, R. Minutolo, Nicola De // NEPHROLOGY, DIALYSIS, TRANSPLANTATION. - 2014. - Vol.29, N4. - P770-774. - 18 ref. . - ISSN 0931-0509
Рубрики: ПОЧЕК БОЛЕЗНИ--KIDNEY DISEASES
   ХРОНИЧЕСКАЯ БОЛЕЗНЬ--CHRONIC DISEASE

   ПРОТЕИНУРИЯ--PROTEINURIA

   СОПУТСТВУЮЩИЕ ФАКТОРЫ (ЭПИДЕМИОЛОГИЯ)--CONFOUNDING FACTORS (EPIDEMIOLOGY)

   СТАРЕНИЕ--AGING

   СМЕРТЬ--DEATH



Дод.точки доступу:
Minutolo, R.; De Nicola, L.
Экз-ры:
Знайти схожі

 
© Міжнародна Асоціація користувачів і розробників електронних бібліотек і нових інформаційних технологій
(Асоціація ЕБНІТ)